Growth Metrics

Rigel Pharmaceuticals (RIGL) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to -$1.0 million.

  • Rigel Pharmaceuticals' Other Gross PP&E Adjustments fell 15925.93% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 15925.93%. This contributed to the annual value of $107000.0 for FY2024, which is 8938.49% down from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Other Gross PP&E Adjustments is -$1.0 million, which was down 15925.93% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $9.7 million in Q4 2022 and a low of -$15.9 million during Q1 2021
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$1.0 million (2025), whereas its average is -$2.5 million.
  • In the last 5 years, Rigel Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 36619.88% in 2021 and then plummeted by 15925.93% in 2025.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Other Gross PP&E Adjustments stood at $6.8 million in 2021, then surged by 42.56% to $9.7 million in 2022, then plummeted by 89.64% to $1.0 million in 2023, then crashed by 89.38% to $107000.0 in 2024, then tumbled by 1081.31% to -$1.0 million in 2025.
  • Its Other Gross PP&E Adjustments was -$1.0 million in Q3 2025, compared to -$1.2 million in Q2 2025 and -$1.3 million in Q1 2025.